The global medical device contract manufacturing market in terms of revenue was estimated to be worth $71.2 billion in 2022 and is poised to reach $118.9 billion by 2027, growing at a CAGR of 10.8% from 2022 to 2027.The new research study consists of an analysis of market industry trends. The new research study includes industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behavior in the market.
The global ultrasound probe disinfection market is expected to grow from $501 million in 2023 to $936 million by 2030, at a CAGR of 13.3%. This growth is driven by the increasing awareness of the importance of high-level disinfection of ultrasound probes, the growing demand for low-cost ultrasonography procedures, and the development of new automated high-level disinfection systems.
The sterilization services market is projected to reach USD 5.9 billion by 2030, at a CAGR of 5.5% during the forecast period. Strict mandates imposed by governments and regulatory bodies in the healthcare industry to maintain GMP compliance, an increase in the number of surgical procedures, and increased outsourcing of sterilisation services by pharmaceutical companies, hospitals, and medical device manufacturers are factors driving the growth of this market
The global patient positioning systems market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.7 billion by 2030, growing at a CAGR of 4.0% from 2023 to 2030. Growing demand for minimally invasive procedures, as well as increasing funding for the construction of new healthcare facilities, are driving market expansion.
The global patient handling equipment market in terms of revenue was estimated to be worth $10.4 billion in 2023 and is poised to reach $14.0 billion by 2030, growing at a CAGR of 6.2% from 2023 to 2030. The current edition of the report consists of an updated market overview along with updated market assessments across all segments from 2023 to 2030.
The global IVD quality control market in terms of revenue was estimated to be worth $1.3 billion in 2022 and is poised to reach $1.6 billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027. The increasing number of accredited clinical laboratories, an ageing population, increased demand for external quality assessment programmes, increased adoption of POC instruments in developed regions, and increased adoption of third-party quality controls are propelling the IVD quality control market forward.
It is expected that from 2022 to 2030, the pharmaceutical sterility testing market, which was valued at USD 1,270.2 million in 2021, would grow at a CAGR of 11.5%. Government spending on healthcare, rising R&D activity, an increase in drug launches, and a growing focus on quality and sterility are all predicted to have a positive impact on the industry. Therefore, clinical research on COVID-19 vaccines is presently being conducted. There is still a need to produce a safe and effective COVID-19 treatment for all the new viral variants. It is projected that the market will profit from the substantial amount of research being done for COVID-19 medications during the post-pandemic era.
Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!
One of our marquee services We profile relevant start-up companies in the market.
Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.
Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.